Cisapride to be nominated as a drug of second choice.
Published: 2000-07-27 16:25:00
Updated: 2000-07-27 16:25:00
The KFDA decided to prohibit Cisapride to be prescribed as a drug of the first choice and seemed to take a serious consideration of its sales ban according to drug informations regarding the adverse reactions like serious cardiovascular hazards.
The KFDA notified to the drug makers of Cisapri...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
